Skip to main content
TipRanks
Go Ultimate75% OFF

Brian Sassi Insider Profile

4 Followers

Brian Sassi, President & CEO Cons, EVP at Elevance Health, holds 60.83K shares in Elevance Health (Ticker: ELV). Most recently, Brian Sassi Sold 200 shares of Elevance Health on Aug 12, 2011 for an estimated value of $13.50K.

Brian Sassi's Trading History

ELV
Elevance Health
Aug 12, 2011President & CEO Cons, EVPInformative Sell13.50K$26.14M
ELV
Insider Shares: 60.83K (0.02%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 12, 2011Informative Buy$13.86K244$56.80-2.40%
Aug 12, 2011Informative Sell$13.50K200$67.500.00%
May 05, 2011Informative Sell$5.55M71,904$77.16+21.80%
Mar 03, 2011Uninformative Sell$593.95K8,921$66.57―
Mar 03, 2011Uninformative Buy$0.008,048$0.00―

You May Also Like

Brian Sassi insider profile FAQ

What is the percentage of profitable transactions made by Brian Sassi?
The percentage of profitable transactions made by Brian Sassi is 50%.
What is the average return per transaction made by Brian Sassi?
The average return per transaction made by Brian Sassi is 6.00%.
What stocks does Brian Sassi hold?
Brian Sassi holds: ELV stocks.
What was Brian Sassi’s latest transaction?
Brian Sassi’s latest transaction was an Informative Sell of $13.50K.
What was Brian Sassi's most profitable transaction?
Brian Sassi’s most profitable transaction was an Informative Sell of ELV stock on May 5, 2011. The return on the trade was 21.80%.
What is Brian Sassi's role in Elevance Health?
Brian Sassi's role in Elevance Health is President & CEO Cons, EVP.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.